Protalix BioTherapeutics, Inc. Note Agreements
7 Contracts & Agreements
- NOTE PURCHASE AGREEMENT (Filed With SEC on July 25, 2017)
- FORM OF FACE OF NOTE (Filed With SEC on July 25, 2017)
- FORM OF NOTE PURCHASE AGREEMENT (Filed With SEC on December 7, 2016)
- Principal Amount $40,186,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible... (Filed With SEC on December 7, 2016)
- Principal Amount $22,500,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible... (Filed With SEC on December 7, 2016)
- ProtalixBioTherapeutics, Inc. $60,000,0004.50% Convertible Notes Due 2018 PurchaseAgreement (Filed With SEC on September 18, 2013)
- [FACE OF NOTE] (Filed With SEC on September 18, 2013)
